Klinifarm SRL
The score of Klinifarm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -33 % Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Klinifarm's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | −44,856 € | ||||
| Equity | 400,612 € | ||||
| Cash | 3,733 € | ||||
| EBITDA | −4,557 € | ||||
| Total assets | 487,335 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 24 Sep 2026
- Year ended 31 Mar 2025filed on 16 Sep 2025
- Year ended 31 Mar 2024filed on 01 Oct 2024
- Year ended 31 Mar 2023filed on 02 Oct 2023
- Year ended 31 Mar 2022filed on 03 Oct 2022
Klinifarm's financial analysis
- Solvency82.2%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Klinifarm
Klinifarm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0434.190.014
- VAT number
- BE0434190014
- Peppol
- Registered · 0208:0434190014 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Apr 1988
- Registered office
- 3500 Hasselt
- Latest accounts
- 2026 · filed on 24 Sep 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Klinifarm (SRL) has been based in Hasselt since 1988, active in: research and experimental development on other natural sciences and engineering. For 2026, it reports a net loss of 44,856 € and equity of 400,612 €; its revenue is not published. Its solvency stands at 82.2%, above the median of its sector (61.7%).
Companies similar to Klinifarm
Companies in the same business, of comparable size and area, outside its group.
- MSI-Dfat EU Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €1.08m
- Research Link Research and experimental development on natural sciences and engineering Thuin · balance sheet 477,442 €
- Calidris Bio Research and experimental development on natural sciences and engineering Antwerp · balance sheet 506,792 €
- HORPI Systems Research and experimental development on natural sciences and engineering Visé · balance sheet 572,679 €
- Sciempath BIO Research and experimental development on natural sciences and engineering Braine-l'Alleud · balance sheet 608,601 €
- Ryp Labs Research and experimental development on natural sciences and engineering Machelen (Brab.) · balance sheet 387,284 €
- BioGenCell Europe SA Research and experimental development on natural sciences and engineering Waterloo · balance sheet 386,698 €
- Polygest Research and experimental development on natural sciences and engineering Pont-à-Celles · balance sheet 380,465 €
Frequently asked questions about Klinifarm
What is the revenue of Klinifarm?
Klinifarm files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Klinifarm?
In Belgium, the VAT number is the company number prefixed with BE: BE0434190014 for Klinifarm, if the company is VAT-registered. Its company number (CBE) is 0434.190.014.
Where is the registered office of Klinifarm?
According to the CBE register, the registered office of Klinifarm is in 3500 Hasselt.
What is the equity of Klinifarm?
At the close of the 2026 financial year, the equity of Klinifarm amounts to 400,612 €, a solvency of 82.2% of total assets.
Who manages Klinifarm?
The register lists 2 active mandates at Klinifarm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Klinifarm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →